140 related articles for article (PubMed ID: 7376941)
1. Evaluation of the humoral response of meningioma patients to possible common tumour-associated antigens.
Mottet S; Martin-Achard A; de Tribolet N; Diserens AC
Acta Neurochir (Wien); 1980; 52(1-2):19-25. PubMed ID: 7376941
[TBL] [Abstract][Full Text] [Related]
2. Autologous antibodies to meningioma cell surface antigens.
Pfreundschuh M; Röhrich M; Piotrowksi W; Penzholz H; Fischer H
Anticancer Res; 1981; 1(6):367-72. PubMed ID: 6284017
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the humoral response of glioma patients to a possible common tumor-associated antigen(s).
Martin-Achard A; Diserens AC; de Tribolet N; Carrel S
Int J Cancer; 1980 Feb; 25(2):219-24. PubMed ID: 7390650
[TBL] [Abstract][Full Text] [Related]
4. Detection of common antigens in primary and recurrent human meningiomas by radioimmunoassays and other serologic tests.
Winters WD
Cancer Detect Prev; 1983; 6(1-2):325-31. PubMed ID: 6883390
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma.
Shih YH; Kadota Y; Sato K; Sueyoshi N; Shirai T
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):193-7. PubMed ID: 7911730
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical demonstration of IgG in meningioma.
Tabuchi K; Kawakami Y; Nishimoto A
Acta Neurochir (Wien); 1981; 55(3-4):201-11. PubMed ID: 7015802
[TBL] [Abstract][Full Text] [Related]
7. Serum immunoglobulins in brain tumours.
Manjula S; Aroor AR; Raja A; Rao SN; Rao A
Acta Neurochir (Wien); 1992; 115(3-4):103-5. PubMed ID: 1605076
[TBL] [Abstract][Full Text] [Related]
8. Serological analysis of tumor antigens in malignant glioma patients.
Yoshida S; Tanaka R; Ono K
Neurol Med Chir (Tokyo); 1991 Sep; 31(9):559-62. PubMed ID: 1723168
[TBL] [Abstract][Full Text] [Related]
9. Impaired thymus-derived lymphocyte function in patients with malignant brain tumour.
Menzies CB; Gunar M; Thomas DG; Behan PO
Clin Neurol Neurosurg; 1980; 82(3):157-68. PubMed ID: 6260411
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic immune response of meningioma patients towards allogeneic and autologous tumour cells before and after surgery.
Pees HW
Acta Neurochir (Wien); 1979; 50(3-4):217-27. PubMed ID: 517190
[TBL] [Abstract][Full Text] [Related]
11. Vaccination for invasive canine meningioma induces in situ production of antibodies capable of antibody-dependent cell-mediated cytotoxicity.
Andersen BM; Pluhar GE; Seiler CE; Goulart MR; SantaCruz KS; Schutten MM; Meints JP; O'Sullivan MG; Bentley RT; Packer RA; Thomovsky SA; Chen AV; Faissler D; Chen W; Hunt MA; Olin MR; Ohlfest JR
Cancer Res; 2013 May; 73(10):2987-97. PubMed ID: 23471847
[TBL] [Abstract][Full Text] [Related]
12. Human meningioma antigens.
Winters WD; Rich JR
Int J Cancer; 1975 May; 15(5):815-22. PubMed ID: 806546
[TBL] [Abstract][Full Text] [Related]
13. Similar immunity profiles in patients with meningioma and glioma tumors despite differences in the apoptosis and necrosis of circulating lymphocyte and monocyte populations.
Kataki A; Skandami V; Memos N; Nikolopoulou M; Oikonomou V; Androulis A; Konstadoulakis MM; Zografos CG
J Neurosurg Sci; 2014 Mar; 58(1):9-15. PubMed ID: 24614787
[TBL] [Abstract][Full Text] [Related]
14. Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets.
Comtesse N; Zippel A; Walle S; Monz D; Backes C; Fischer U; Mayer J; Ludwig N; Hildebrandt A; Keller A; Steudel WI; Lenhof HP; Meese E
Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9601-6. PubMed ID: 15983380
[TBL] [Abstract][Full Text] [Related]
15. Human intracranial tumors: effect of autologous serum addition on leucocyte migration inhibition.
Böker DK
Acta Neurochir (Wien); 1982; 65(3-4):227-37. PubMed ID: 7180599
[TBL] [Abstract][Full Text] [Related]
16. Novel immunogenic antigens increase classification accuracy in meningioma to 93.84%.
Ludwig N; Keller A; Heisel S; Leidinger P; Rheinheimer S; Andres C; Stephan B; Steudel WI; Donauer E; Graf N; Burgeth B; Weickert J; Lenhof HP; Meese E
Int J Cancer; 2011 Mar; 128(6):1493-501. PubMed ID: 20506373
[TBL] [Abstract][Full Text] [Related]
17. The utilization of native glioma antigens in the assessment of cellular and humoral immune responses in malignant glioma patients.
Apuzzo ML; Sheikh KM; Weiss MH; Heiden JS; Kurze T
Acta Neurochir (Wien); 1981; 55(3-4):181-200. PubMed ID: 7015801
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence automatic cell sorter and immunohistochemical investigation of CD68-positive cells in meningioma.
Asai J; Suzuki R; Fujimoto T; Suzuki T; Nakagawa N; Nagashima G; Miyo T; Hokaku H; Takei A
Clin Neurol Neurosurg; 1999 Dec; 101(4):229-34. PubMed ID: 10622450
[TBL] [Abstract][Full Text] [Related]
19. Specific cellular immune responses in patients with malignant gliomas.
Sheikh KM; Apuzzo ML; Weiss MH
Cancer Res; 1979 May; 39(5):1733-8. PubMed ID: 85487
[TBL] [Abstract][Full Text] [Related]
20. Common antigen in meningioma-derived cell cultures.
Catalano LW; Harter DH; Hsu KC
Science; 1972 Jan; 175(4018):180-2. PubMed ID: 4332758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
